Response to "Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics", by Dannecker et al. (Ann Oncol 2004; 15: 863-869) and "Histopathological validation of the sentinel node concept in cervical cancer", by Barranger et al. (Ann Oncol 2004; 15: 870-874): DNA microarrays will be instrumental in the future diagnosis of cervical dysplasia and neoplasia.
Wright
P K
PK
D000554:Ambulatory Care Facilities; D015344:DNA Probes, HPV / Q000235:genetics; D005260:Female; D006801:Humans; D007388:Internal Medicine; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods*; D021701:Sentinel Lymph Node Biopsy / Q000379:methods*; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis* / Q000235:genetics; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000821:virology
D015344:DNA Probes, HPV